Suppr超能文献

[人胃癌、肝癌、胆囊癌及正常肝组织中的雌激素受体]

[Estrogen receptors in human gastric, hepatocellular, and gallbladder carcinomas and normal liver tissues].

作者信息

Ohnami S, Nakata H, Nagafuchi Y, Zeze F, Eto S

机构信息

Dept. of Radiology, School of Medicine, University of Occupational and Environmental Health, Kitakyushu.

出版信息

Gan To Kagaku Ryoho. 1988 Oct;15(10):2923-8.

PMID:2845868
Abstract

Steroid binding assay using the dextran coated charcoal (DCC) method was applied to human tissues including tumors of the digestive organs, and the results were compared with those of enzymeimmunoassay (EIA) and immunocytochemical assay (ICA) with monoclonal antibody against human estrogen receptor of MCF-7 breast cancer cells. Using the DCC method, estrogen receptor activity was detected in 6 of 26 cases (23.1%) with gastric carcinoma, 3 of 16 hepatocellular carcinoma cases (18.8%), 1 of 3 gallbladder carcinoma cases (33.3%), and both of the 2 cases (100%) with normal liver tissue. However, using EIA, no ER activity was detected in any case. Moreover, ER positive cells were not found by immunohistochemical staining in the gastric carcinoma cases or in normal liver tissue, both of which showed ER activity by the DCC method. These results suggest that the estrogen receptor like material exists in cytosol of the human digestive tumors and normal liver tissue, but that the specificity of the antibodies against estrogen receptor molecules in these tumors may be different from that of the breast tumors.

摘要

采用葡聚糖包被活性炭(DCC)法对包括消化器官肿瘤在内的人体组织进行类固醇结合测定,并将结果与使用抗MCF-7乳腺癌细胞人雌激素受体单克隆抗体的酶免疫测定(EIA)和免疫细胞化学测定(ICA)结果进行比较。使用DCC法,在26例胃癌病例中有6例(23.1%)检测到雌激素受体活性,16例肝细胞癌病例中有3例(18.8%),3例胆囊癌病例中有1例(33.3%),2例正常肝组织病例均检测到(100%)。然而,使用EIA法,在任何病例中均未检测到雌激素受体活性。此外,在胃癌病例或正常肝组织中,通过免疫组织化学染色未发现雌激素受体阳性细胞,而这两种组织通过DCC法均显示有雌激素受体活性。这些结果表明,人消化肿瘤和正常肝组织的胞质中存在雌激素受体样物质,但这些肿瘤中抗雌激素受体分子抗体的特异性可能与乳腺肿瘤不同。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验